RA Capital Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-692,794
Closed -$51M 96
2022
Q1
$51M Sell
692,794
-1,405,000
-67% -$125M 1.11% 29
2021
Q4
$300M Hold
2,097,794
5.29% 2
2021
Q3
$435M Sell
2,097,794
-462,124
-18% -$102M 6.03% 2
2021
Q2
$543M Sell
2,559,918
-442,169
-15% -$81M 8.72% 2
2021
Q1
$544M Sell
3,002,087
-786,477
-21% -$157M 8.21% 2
2020
Q4
$422M Buy
3,788,564
+2,589,962
+216% +$275M 5.91% 3
2020
Q3
$130M Sell
1,198,602
-3,560,231
-75% -$434M 2.38% 10
2020
Q2
$397M Buy
+4,758,833
New +$182M 7.73% 3
2015
Q4
Sell
-8,103
Closed -$1.15M 43
2015
Q3
$1.15M Sell
8,103
-63,459
-89% -$14.2M 0.16% 42
2015
Q2
$15.9M Hold
71,562
1.6% 21
2015
Q1
$11.8M Sell
71,562
-90,492
-56% -$14.7M 1.18% 22
2014
Q4
$19.2M Sell
162,054
-91,300
-36% -$9.54M 2.07% 16
2014
Q3
$21.1M Sell
253,354
-79,733
-24% -$7.21M 2.5% 14
2014
Q2
$30.8M Sell
333,087
-163,826
-33% -$14.4M 3.11% 11
2014
Q1
$45M Sell
496,913
-43,681
-8% -$4.88M 3.23% 14
2013
Q4
$55.4M Sell
540,594
-499,406
-48% -$35.3M 6.45% 5
2013
Q3
$65.5M Buy
1,040,000
+181,460
+21% +$10.2M 6.84% 3
2013
Q2
$35.2M Buy
+858,540
New +$37.2M 4.67% 8

Other funds holding NVAX

RA Capital Management's NVAX Position: Q2 2022 in Review

RA Capital Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 692,794 shares — an estimated $51M sold.

RA Capital Management first reported a position in NVAX in Q2 2013 and held it in 18 quarters. The position peaked at $544M in Q1 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • RA Capital Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • RA Capital Management sold 692,794 Novavax shares in Q2 2022, an estimated $51M.
  • RA Capital Management first reported a position in Novavax in Q2 2013 and held it in 18 quarters.
  • RA Capital Management's Novavax position peaked at $544M in Q1 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on RA Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.